Perforomist (formoterol) is a brand-name drug that’s prescribed for chronic obstructive pulmonary disease (COPD) in adults. Perforomist comes as a liquid that’s inhaled with a nebulizer twice per day.

Please provide your email address to receive an email when new articles are posted on . Ensifentrine had favorable efficacy and safety profiles in two phase 3 trials. Verona Pharma is prepared for ...

Medicare classifies nebulizers as durable medical equipment (DME), which is covered under Part B. Part A may cover costs if needed during inpatient care in a clinic, hospital, or nursing facility.

The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National ...

Clarified return terms. When marketing language and Terms of Service provisions present different expectations, reconciling them proactively builds consumer trust. This applies to NebuEase's guarantee ...

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes. Objectives: Despite ...

"Physicians should feel more confident in following the recent guideline recommendations both to use race-neutral reference equations and to use z scores for assessing severity…Together, these changes ...